✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹3,619 Cr.
P/E
36.31

Key Ratios

Market cap
Market cap
3,619 Cr
PE
PE
36.31
Prom Holding
Prom Holding
69.84 %
ROE (%)
ROE (%)
7.88
ROCE (%)
ROCE (%)
8.40
Div Yield (%)
Div Yield (%)
-
Sales
Sales
921 Cr
OPM (%)
OPM (%)
12.71 %
Debt to Equity
Debt to Equity
0.12
About
Orchid Pharma is a vertically integrated pharmaceutical company with expertise in research, ma… Read more
Low
604
52W Range
High
1997
  • Orchid Pharma
  • Gufic Biosciences
  • Guj. Themis Biosyn

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

7 Yes

Positive for this company

3 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up - Geography Wise

Peer Comparison
FAQs on Orchid Pharma Ltd. Business

Orchid Pharma is a vertically integrated pharmaceutical company with expertise in research, manufacturing, and marketing. They offer a wide range of pharmaceutical solutions and have a global presence through strategic alliances.

Orchid Pharma major competitors are Gufic Biosciences, Guj. Themis Biosyn, Unichem Lab, Zota Health Care, Indoco Remedies, Panacea Biotec, Novartis.
Market Cap of Orchid Pharma is ₹3,589 Crs.
While the median market cap of its peers are ₹2,930 Crs.

Orchid Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Mar Jun Sep Sep Dec
Investor Presentation May Mar Jun Sep Dec Jun Sep Dec Mar Jun Aug Sep Dec Mar Sep Dec
Conference Call Mar Mar Jun Sep Dec Mar Jun Sep Dec Sep Dec
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material